人工智能在心力衰竭中的新兴作用
Brett S Bernstein1,2, Sona Streather3, Kevin O'Gallagher1,2
1School of Cardiovascular and Metabolic Medicine & Sciences, British Heart Foundation Centre of Research Excellence, King's College London, London, UK.
Future cardiology
|July 4, 2025
概括
人工智能 (AI) 可以分析心力衰竭患者的数据,以改善诊断,风险分层和治疗. 人工智能为新生物标志物和药物开发提供了新的见解,有利于心力衰竭管理的未来.
科学领域:
- 心脏病学 心脏病学
- 医疗信息学 医疗信息学
- 人工智能的人工智能
背景情况:
- 心力衰竭 (HF) 是一种普遍的疾病,患病率和死亡率很高.
- 来自HF患者的数字化医疗数据为分析提供了机会.
- 现有的数据分析方法在捕捉高频的复杂性方面存在局限性.
研究的目的:
- 探索人工智能 (AI) 在分析心力衰竭患者数据中的应用.
- 确定人工智能如何提高心力衰竭的诊断,风险分层和治疗策略.
- 突出AI在发现新生物标志物的潜力,并加速治疗心力衰竭的药物开发.
主要方法:
- 人工智能系统以易于获取的数据 (如心电图和心脏声) 进行训练,以评估高频率的可能性.
- 对综合医疗保健数据进行分析,以对患者风险分层进行分析.
- 自动回声心电图分析用于快速分组患者和识别新型成像生物标志物 (例如第一阶段射出分数).
主要成果:
- 人工智能可以使用各种数据类型准确评估心力衰竭的可能性.
- 人工智能能够有效地分层心力衰竭患者的风险.
- 人工智能有助于识别新的成像生物标志物,超出了传统的指标,如左心室喷射率.
- 人工智能有助于评估患者是否适合使用现有药物,并支持开发新药.
结论:
- 人工智能对通过数据分析推进心力衰竭护理具有重大前景.
- 人工智能应用可以带来更个性化,更有效的心力衰竭管理策略.
- 人工智能融入心脏病学预计将在未来二十年内推动心力衰竭结果的大幅改善.
相关概念视频
01:22Heart Failure VI: Adjunct Therapies
36
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
36
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
516
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
516
01:30Heart Failure V: Medical Management
29
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
29
01:30Heart Failure IV: Classification and Diagnostic Evaluation
38
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
38
01:29Heart Failure II: Pathophysiology
51
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
51
01:27Heart Failure I: Introduction
62
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
62